Author/Authors :
Rezasoltani, Sama Shahid Beheshti University of Medical Sciences, Tehran , Asadzadeh-Aghdaei, Hamid Shahid Beheshti University of Medical Sciences, Tehran , Nazemalhosseini-Mojarad, Ehsan Shahid Beheshti University of Medical Sciences, Tehran , Dabiri, Hossein Department of Medical Microbiology - School of Medicine - Shahid Beheshti University of Medical Sciences, Tehran , Ghanbari, Reza Tehran University of Medical Sciences, Tehran , Zali, Mohammad Reza Shahid Beheshti University of Medical Sciences, Tehran
Abstract :
Micro-organisms contain 90% of cells in human body and trillions foreign genes versus less than 30 thousand of their own.
The human colon host various species of microorganisms, appraised at more than 1014 microbiota and contained of over a
thousand species. Although each one’s profile is separable, the relative abundance and distribution of bacterial species is
the same between healthy ones, causing conservation of each person’s overall health. Germline DNA mutations have been
attributed to the less than 5% of CRC occurrence while more than 90% is associated with the epigenetic regulation. The
most ubiquitous environmental factor in epigenetic modification is gut microbiota. Disruptive changes in the gut microbiome
strongly contributed to the improvement of colorectal cancer. Gut microbiota may play critical role in progression of CRC
via their metabolite or their structural component interacting with host intestinal epithelial cell (IEC). Herein we discuss the
mechanism of epigenetic modification and its implication in CRC development, progression even metastasis by gut microbiota
induction.